ValiRx plc (AIM:VAL)
London
· Delayed Price · Currency is GBP · Price in GBX 0.6500
+0.0500 (8.33%)
Jul 4, 2025, 11:10 AM GMT+1
ValiRx Revenue
In the year 2024, ValiRx had annual revenue of 49.78K GBP with 418.49% growth. ValiRx had revenue of 49.78K in the half year ending December 31, 2024.
Revenue
49.78K
Revenue Growth
+418.49%
P/S Ratio
45.12
Revenue / Employee
3.11K
Employees
16
Market Cap
2.25M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
ValiRx News
- 7 months ago - Small Cap Stocks: Catenai, Genip, ValiRx - The Armchair Trader
- 8 months ago - Small Cap Stocks: Guardian Metal, MediaZest, Enwell - The Armchair Trader
- 9 months ago - Small Cap Stocks: Valirx, EnergyPathways, Merit Group - The Armchair Trader